search
Back to results

AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma

Primary Purpose

Asthma

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Active Air Purifier
Placebo Air Purifier
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Asthma

Eligibility Criteria

8 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. 8-17 years of age
  2. Persistent asthma (NAEPP criteria)
  3. Exacerbation in previous 12 months
  4. Non-smoker
  5. Spends ≥4 nights/week at home
  6. No plans to move during the study

Exclusion Criteria:

  1. Significant pulmonary or cardiac disease
  2. Home not appropriate candidate due to disrepair
  3. Underweight, defined by BMI <5th percentile
  4. Pregnancy

Sites / Locations

  • Meredith McCormack

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Active Air Purifier

Placebo Air Purifier

Arm Description

Two portable air purifiers containing HEPA filters will be placed in the bedroom and room where the participant reports spending the most time. We have chosen to deploy two air purifiers because we have observed a 50% reduction in indoor PM concentrations with two air purifiers. Participants will be instructed to run the air purifiers continually. Participants will receive educational materials about environmental factors that are important for asthma health and environmental modification strategies. Participants will also receive educational materials about health benefits of maintaining a normal weight.

Homes in the control group will receive placebo air purifiers that have the internal air filters removed, but which will run normally. Participants will receive educational materials about environmental factors that are important for asthma health and environmental modification strategies, and educational materials about health benefits of maintaining a normal weight. At the end of the study, participants in the control group will receive active air purifiers. A control group is needed to ensure that reduced pollutant levels and health effects are not due to temporal trends and 'placebo effects' of being enrolled in an intervention trial. Participants will also be informed that being in the study does not prevent them from purchasing and using air cleaners during the study period.

Outcomes

Primary Outcome Measures

Maximum Symptom Days
We have chosen symptoms based on the strong relationship between symptoms and PM observed in previous studies. Symptoms during the previous two weeks will be captured with standardized questions used in many inner-city asthma studies, including our own that detected a strong association between indoor PM and asthma symptoms. A 'maximum symptom days' variable will constructed as the maximum of the variables: days of slowed activity, days of wheezing, coughing or chest tightness when running or going upstairs, and nights of waking with asthma symptoms in the past two weeks. We will administer questionnaires to the primary caregiver of children 8-11 years and to both participant and caregiver for adolescents age 12-17. Previous studies have indicated concordance between adolescent and the caregiver responses, and we will collect data to assess concordance within our study population. Individual symptom variables will serve as secondary outcomes.

Secondary Outcome Measures

Asthma Control
Asthma Control Questionnaire (ACT). This questionnaire assesses asthma control and a score of less than 19 has been linked to poor asthma control. The Asthma Therapy Assessment Questionnaire includes questions about asthma control and will also be used.
Asthma Symptoms
The Asthma Symptom Utility Index (ASUI) will be used to assess asthma symptoms.
Health Care Utilization
Child participants and caregivers will be asked about acute health care encounters during the study, including unscheduled doctor visits, Emergency Department visits, and hospitalizations. Acute visits occurred in approximately 30% of our previous study populations during a 3 month period.
Lung Function
Pre- and post-bronchodilator forced expiratory vital capacity in the first second/forced vital capacity (FEV1/FVC) and FEV1 will be measured and interpreted according to the American Thoracis Society (ATS) guidelines using NHANES predicted equations.
FENO
Exhaled nitric oxide (FENO) will provide a non-invasive means of assessing pulmonary inflammation in a large cohort of children. Measurements will be obtained prior to lung function according to the American Thoracic Society Guidelines with handheld, FDA-approved analyzer (NIOX System, Aerocrine, Sweden)

Full Information

First Posted
May 3, 2016
Last Updated
October 17, 2023
Sponsor
Johns Hopkins University
Collaborators
National Institute of Environmental Health Sciences (NIEHS)
search

1. Study Identification

Unique Protocol Identification Number
NCT02763917
Brief Title
AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma
Official Title
AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 2016 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University
Collaborators
National Institute of Environmental Health Sciences (NIEHS)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background: Asthma and obesity are public health crises that have concurrently risen over the past decades, affecting millions of children in the United States and disproportionately affecting low-income minority children in urban areas. The same children at highest risk for asthma and obesity also have greater exposure to indoor and outdoor pollution. Emerging evidence suggests that obesity may confer increased susceptibility to health effects of air pollution. Methods: Aiming to provide causal-level evidence of these observational findings, we propose a home intervention study to 1) test whether targeted reductions of indoor Particulate Matter (PM) concentrations improve the respiratory health of overweight inner-city children with asthma more than that of lean inner-city children with asthma and 2) investigate mediators of susceptibility to indoor PM among overweight versus lean children with asthma. We will accomplish these aims using a 1:1 randomized controlled trial of 200 children with persistent asthma (half normal weight, half overweight) living in Baltimore City. Participants will be randomized to receive either two active air purifiers containing high-efficiency particulate air (HEPA) filters or two sham air purifiers with their filters removed. Implications: If the aforementioned observational findings are confirmed, implications will be directly relevant to the over 170 million children around the world now estimated to be overweight or obese.
Detailed Description
The primary object of this study is to determine the efficacy of a targeted environmental intervention among overweight inner city children as compared to normal weight inner city children with asthma. Specific Aim #1: To determine if overweight inner-city children, compared to lean inner-city children, have greater improvement in asthma with an air purifier intervention aimed at reducing indoor PM. Hypothesis 1: An intervention using HEPA filter air purifiers in the homes of inner-city children with asthma will be associated with greater respiratory improvement in overweight children than in normal weight children. Specific Aim #2a: To investigate mediators of susceptibility among overweight versus normal weight children with asthma. Hypothesis #2. Candidate mediators, including increases in a) tidal volume and thereby increases in doses of inhaled particles, b) inflammatory and oxidative stress responses, c) corticosteroid resistance, and d) sleep disordered breathing mediate increased susceptibility to indoor PM among overweight versus normal weight children with asthma. Children with asthma will be enrolled in the study for about 16 weeks. They will have three clinic visits, an overnight sleep study, and two home environmental assessments for one week each. They will have a home and clinical assessment before randomization and another home and clinical assessment about 12 weeks after randomization. The primary outcome measure is maximum number of asthma symptom days.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
198 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active Air Purifier
Arm Type
Active Comparator
Arm Description
Two portable air purifiers containing HEPA filters will be placed in the bedroom and room where the participant reports spending the most time. We have chosen to deploy two air purifiers because we have observed a 50% reduction in indoor PM concentrations with two air purifiers. Participants will be instructed to run the air purifiers continually. Participants will receive educational materials about environmental factors that are important for asthma health and environmental modification strategies. Participants will also receive educational materials about health benefits of maintaining a normal weight.
Arm Title
Placebo Air Purifier
Arm Type
Placebo Comparator
Arm Description
Homes in the control group will receive placebo air purifiers that have the internal air filters removed, but which will run normally. Participants will receive educational materials about environmental factors that are important for asthma health and environmental modification strategies, and educational materials about health benefits of maintaining a normal weight. At the end of the study, participants in the control group will receive active air purifiers. A control group is needed to ensure that reduced pollutant levels and health effects are not due to temporal trends and 'placebo effects' of being enrolled in an intervention trial. Participants will also be informed that being in the study does not prevent them from purchasing and using air cleaners during the study period.
Intervention Type
Device
Intervention Name(s)
Active Air Purifier
Intervention Description
Two portable air purifiers containing HEPA filters will be placed in the bedroom and room where the participant reports spending the most time. Participants will be instructed to run the air purifiers continually. Participants will receive educational materials about environmental factors that are important for asthma health and environmental modification strategies, and educational materials about health benefits of maintaining a normal weight.
Intervention Type
Device
Intervention Name(s)
Placebo Air Purifier
Intervention Description
Homes in the control group will receive placebo air purifiers that have the internal air filters removed, but which will run normally. Participants will receive educational materials about environmental factors that are important for asthma health and environmental modification strategies, and educational materials about health benefits of maintaining a normal weight. At the end of the study, participants in the control group will receive active air purifiers. A control group is needed to ensure that reduced pollutant levels and health effects are not due to temporal trends and 'placebo effects' of being enrolled in an intervention trial. Participants will be informed that being in the study does not prevent them from purchasing and using air cleaners during the study period.
Primary Outcome Measure Information:
Title
Maximum Symptom Days
Description
We have chosen symptoms based on the strong relationship between symptoms and PM observed in previous studies. Symptoms during the previous two weeks will be captured with standardized questions used in many inner-city asthma studies, including our own that detected a strong association between indoor PM and asthma symptoms. A 'maximum symptom days' variable will constructed as the maximum of the variables: days of slowed activity, days of wheezing, coughing or chest tightness when running or going upstairs, and nights of waking with asthma symptoms in the past two weeks. We will administer questionnaires to the primary caregiver of children 8-11 years and to both participant and caregiver for adolescents age 12-17. Previous studies have indicated concordance between adolescent and the caregiver responses, and we will collect data to assess concordance within our study population. Individual symptom variables will serve as secondary outcomes.
Time Frame
Baseline and about 12 weeks after the intervention
Secondary Outcome Measure Information:
Title
Asthma Control
Description
Asthma Control Questionnaire (ACT). This questionnaire assesses asthma control and a score of less than 19 has been linked to poor asthma control. The Asthma Therapy Assessment Questionnaire includes questions about asthma control and will also be used.
Time Frame
Baseline and about 12 weeks after the intervention
Title
Asthma Symptoms
Description
The Asthma Symptom Utility Index (ASUI) will be used to assess asthma symptoms.
Time Frame
Baseline and about 12 weeks after the intervention
Title
Health Care Utilization
Description
Child participants and caregivers will be asked about acute health care encounters during the study, including unscheduled doctor visits, Emergency Department visits, and hospitalizations. Acute visits occurred in approximately 30% of our previous study populations during a 3 month period.
Time Frame
Baseline and about 12 weeks after the intervention
Title
Lung Function
Description
Pre- and post-bronchodilator forced expiratory vital capacity in the first second/forced vital capacity (FEV1/FVC) and FEV1 will be measured and interpreted according to the American Thoracis Society (ATS) guidelines using NHANES predicted equations.
Time Frame
Baseline and about 12 weeks after the intervention.
Title
FENO
Description
Exhaled nitric oxide (FENO) will provide a non-invasive means of assessing pulmonary inflammation in a large cohort of children. Measurements will be obtained prior to lung function according to the American Thoracic Society Guidelines with handheld, FDA-approved analyzer (NIOX System, Aerocrine, Sweden)
Time Frame
Baseline and about 12 weeks after the intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 8-17 years of age Persistent asthma (NAEPP criteria) Exacerbation in previous 12 months Non-smoker Spends ≥4 nights/week at home No plans to move during the study Exclusion Criteria: Significant pulmonary or cardiac disease Home not appropriate candidate due to disrepair Underweight, defined by BMI <5th percentile Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Meredith C. McCormack, MD, MHS
Organizational Affiliation
Johns Hopkins University, Pulmonary and Critical Care Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Meredith McCormack
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33625291
Citation
Kaviany P, Brigham EP, Collaco JM, Rice JL, Woo H, Wood M, Koehl R, Wu TD, Eakin MN, Koehler K, Hansel NN, McCormack MC. Patterns and predictors of air purifier adherence in children with asthma living in low-income, urban households. J Asthma. 2022 May;59(5):946-955. doi: 10.1080/02770903.2021.1893745. Epub 2021 Mar 10.
Results Reference
derived

Learn more about this trial

AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma

We'll reach out to this number within 24 hrs